These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 38190026)

  • 1. Mediation effect of antithrombin III between chronic renal insufficiency and chronic coronary artery disease in T2DM patients.
    Sun R; Jia J; Wang S; Wang Z; Wang C; Xu Y; Yuan Y
    Endocrine; 2024 Jun; 84(3):924-933. PubMed ID: 38190026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma concentrations of osteopontin, but not thrombin-cleaved osteopontin, are associated with the presence and severity of nephropathy and coronary artery disease in patients with type 2 diabetes mellitus.
    Yan X; Sano M; Lu L; Wang W; Zhang Q; Zhang R; Wang L; Chen Q; Fukuda K; Shen W
    Cardiovasc Diabetol; 2010 Oct; 9():70. PubMed ID: 21034455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of serum levels of glycated albumin, C-reactive protein and tumor necrosis factor-alpha with the severity of coronary artery disease and renal impairment in patients with type 2 diabetes mellitus.
    Lu L; Pu LJ; Xu XW; Zhang Q; Zhang RY; Zhang JS; Hu J; Yang ZK; Lu AK; Ding FH; Shen J; Chen QJ; Lou S; Fang DH; Shen WF
    Clin Biochem; 2007 Jul; 40(11):810-6. PubMed ID: 17499233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated blood urea nitrogen-to-creatinine ratio increased the risk of Coronary Artery Disease in patients living with type 2 diabetes mellitus.
    Liu F; Ma G; Tong C; Zhang S; Yang X; Xu C; Yang W; Xia G; Li M
    BMC Endocr Disord; 2022 Feb; 22(1):50. PubMed ID: 35227230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between coronary artery disease and C-reactive protein levels in NSTEMI patients with renal dysfunction: a retrospective study.
    Udeanu M; Guizzardi G; Di Pasquale G; Marchetti A; Romani F; Dalmastri V; Capelli I; Stalteri L; Cianciolo G; Rucci P; La Manna G
    BMC Nephrol; 2014 Sep; 15():152. PubMed ID: 25230678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein E gene polymorphism: effects on plasma lipids and risk of type 2 diabetes and coronary artery disease.
    Chaudhary R; Likidlilid A; Peerapatdit T; Tresukosol D; Srisuma S; Ratanamaneechat S; Sriratanasathavorn C
    Cardiovasc Diabetol; 2012 Apr; 11():36. PubMed ID: 22520940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antithrombin III Protects Against Contrast-Induced Nephropathy.
    Lu Z; Cheng D; Yin J; Wu R; Zhang G; Zhao Q; Wang N; Wang F; Liang M
    EBioMedicine; 2017 Mar; 17():101-107. PubMed ID: 28219627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between triglyceride glucose index and coronary artery disease with type 2 diabetes mellitus in middle-aged and elderly people.
    Si Y; Fan W; Shan W; Zhang Y; Liu J; Han C; Sun L
    Medicine (Baltimore); 2021 Mar; 100(9):e25025. PubMed ID: 33655974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of lipoprotein(a) and coronary artery disease in 1003 patients with stage 3-5 chronic kidney disease undergoing coronary angiography.
    Lin LH; Liu H; Tu Y; Yang Y; Wang B; Wang FM; Wu M; Pan MM; Tang RN; Ma KL; Zhang XL; Liu BC
    Coron Artery Dis; 2019 Mar; 30(2):137-142. PubMed ID: 30585793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronary Artery Disease Is a Predictor of Progression to Dialysis in Patients With Chronic Kidney Disease, Type 2 Diabetes Mellitus, and Anemia: An Analysis of the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT).
    Sabe MA; Claggett B; Burdmann EA; Desai AS; Ivanovich P; Kewalramani R; Lewis EF; McMurray JJ; Olson KA; Parfrey P; Solomon SD; Pfeffer MA
    J Am Heart Assoc; 2016 Apr; 5(4):. PubMed ID: 27108247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of preventative cardiovascular therapies on coronary artery disease in people with and without type 2 diabetes: a propensity-matched score study.
    Kiburg KV; MacIsaac AI; McCluskey GE; Sundararajan V; MacIsaac RJ
    BMC Cardiovasc Disord; 2021 Sep; 21(1):463. PubMed ID: 34565341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased Th1 and suppressed Th2 serum cytokine levels in subjects with diabetic coronary artery disease.
    Madhumitha H; Mohan V; Deepa M; Babu S; Aravindhan V
    Cardiovasc Diabetol; 2014 Jan; 13():1. PubMed ID: 24383855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated lipoprotein (a) levels are associated with the presence and severity of coronary artery disease in patients with type 2 diabetes mellitus.
    Zhang HW; Zhao X; Guo YL; Gao Y; Zhu CG; Wu NQ; Li JJ
    Nutr Metab Cardiovasc Dis; 2018 Oct; 28(10):980-986. PubMed ID: 30030022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of renal function on mean platelet volume and its relationship with coronary artery disease: A single-centre cohort study.
    Verdoia M; Barbieri L; Schaffer A; Bellomo G; Marino P; De Luca G;
    Thromb Res; 2016 May; 141():139-44. PubMed ID: 27039166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial 8-hydroxy-2'-deoxyguanosine and coronary artery disease in patients with type 2 diabetes mellitus.
    Wang XB; Cui NH; Liu X; Liu X
    Cardiovasc Diabetol; 2020 Feb; 19(1):22. PubMed ID: 32075646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroperative effects of fresh frozen plasma and antithrombin III on heparin sensitivity and coagulation during nitroglycerine infusion in coronary artery bypass surgery.
    Kanbak M; Oc B; Salman MA; Ocal T; Oc M
    Blood Coagul Fibrinolysis; 2011 Oct; 22(7):593-9. PubMed ID: 21799398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High plasma chemerin is associated with renal dysfunction and predictive for cardiovascular events - Insights from phenotype and genotype characterization.
    Leiherer A; Muendlein A; Kinz E; Vonbank A; Rein P; Fraunberger P; Malin C; Saely CH; Drexel H
    Vascul Pharmacol; 2016 Feb; 77():60-8. PubMed ID: 26304698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating osteopontin as a marker of early coronary vascular calcification in type two diabetes mellitus patients with known asymptomatic coronary artery disease.
    Berezin AE; Kremzer AA
    Atherosclerosis; 2013 Aug; 229(2):475-81. PubMed ID: 23880208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and risk factors for chronic kidney disease in patients with coronary artery disease.
    Bao YS; Na SP; Jia XB; Liu RC; Wang MA; Yu CY; Mu SH; Xie RJ
    Curr Med Res Opin; 2012 Mar; 28(3):379-84. PubMed ID: 22335251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-sensitivity troponin I and B-type natriuretic peptide biomarkers for prediction of cardiovascular events in patients with coronary artery disease with and without diabetes mellitus.
    Wong YK; Cheung CYY; Tang CS; Hai JSH; Lee CH; Lau KK; Au KW; Cheung BMY; Sham PC; Xu A; Lam KSL; Tse HF
    Cardiovasc Diabetol; 2019 Dec; 18(1):171. PubMed ID: 31847896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.